Soleno Therapeutics, Inc. (SLNO) financial statements (2022 and earlier)
Company profile
| Business Address |
203 REDWOOD SHORES PARKWAY REDWOOD CITY, CA 94065 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 21,304 | 49,224 | 20,733 | 23,099 | 17,100 | 2,726 | 5,495 | ||
| Cash and cash equivalents | 21,304 | 49,224 | 20,733 | 23,099 | 17,100 | 2,726 | 5,495 | ||
| Restricted cash and investments | 35 | 35 | 35 | ||||||
| Receivables | 64 | 133 | 156 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 660 | 551 | |||||||
| Inventory | 660 | 551 | |||||||
| Other undisclosed current assets | 1,118 | 1,019 | 411 | 1,507 | 859 | 247 | 168 | ||
| Total current assets: | 22,422 | 50,243 | 21,144 | 24,670 | 17,994 | 3,801 | 6,404 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset | 15 | 24 | ✕ | ✕ | ✕ | ✕ | |||
| Operating lease, right-of-use asset | 421 | 124 | 398 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 33 | 19 | 22 | 12 | 23 | 103 | 86 | ||
| Intangible assets, net (including goodwill) | 12,637 | 14,581 | 16,525 | 18,469 | 20,413 | 943 | 993 | ||
| Goodwill | 817 | 917 | |||||||
| Intangible assets, net (excluding goodwill) | 12,637 | 14,581 | 16,525 | 18,469 | 20,413 | 126 | 76 | ||
| Other noncurrent assets | 40 | 59 | 126 | 718 | 718 | ||||
| Other undisclosed noncurrent assets | 466 | ||||||||
| Total noncurrent assets: | 13,131 | 14,739 | 17,028 | 18,481 | 21,028 | 1,764 | 1,797 | ||
| TOTAL ASSETS: | 35,553 | 64,982 | 38,172 | 43,151 | 39,022 | 5,565 | 8,201 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,982 | 4,494 | 2,278 | 934 | 633 | 538 | 695 | ||
| Accounts payable | 3,254 | 3,489 | 1,995 | 934 | 633 | 538 | 695 | ||
| Employee-related liabilities | 728 | 1,005 | 283 | ||||||
| Debt | 8 | 322 | |||||||
| Derivative instruments and hedges, liabilities | 865 | ||||||||
| Disposal group, including discontinued operation | 127 | ||||||||
| Other liabilities | 323 | 196 | 382 | ||||||
| Other undisclosed current liabilities | 3,702 | 3,920 | 1,982 | 943 | 973 | 1,169 | 1,633 | ||
| Total current liabilities: | 8,007 | 8,618 | 4,964 | 1,877 | 1,733 | 1,707 | 3,193 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 175 | 147 | |||||||
| Finance lease, liability | 8 | ✕ | ✕ | ✕ | ✕ | ||||
| Operating lease, liability | 175 | 139 | ✕ | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 147 | 4,062 | 9,737 | 143 | 109 | ||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | 4,062 | 4,417 | ||||
| Disposal group, including discontinued operation, liabilities | 225 | ||||||||
| Other liabilities | 147 | 13 | 143 | 109 | |||||
| Business combination, contingent consideration, liability | 5,082 | ||||||||
| Other undisclosed noncurrent liabilities | 9,403 | 10,817 | 17,967 | 6,799 | 1,017 | 280 | |||
| Total noncurrent liabilities: | 9,753 | 10,817 | 18,261 | 10,861 | 10,754 | 422 | 109 | ||
| Total liabilities: | 17,760 | 19,435 | 23,225 | 12,738 | 12,487 | 2,130 | 3,302 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 17,793 | 45,547 | 14,947 | 30,413 | 26,535 | 3,435 | 3,224 | ||
| Common stock | 80 | 80 | 45 | 32 | 19 | 17 | 14 | ||
| Additional paid in capital | 231,068 | 227,912 | 172,708 | 157,413 | 140,495 | 101,730 | 89,456 | ||
| Accumulated deficit | (213,355) | (182,445) | (157,806) | (127,032) | (113,979) | (98,312) | (86,247) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | 0 | 0 | ||||||
| Total stockholders' equity: | 17,793 | 45,547 | 14,947 | 30,413 | 26,535 | 3,435 | 3,224 | ||
| Other undisclosed liabilities and equity | 1,675 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 35,553 | 64,982 | 38,172 | 43,151 | 39,022 | 5,565 | 8,201 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 173 | 1,451 | 607 | |||||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 1,451 | 607 | ||
| Sublease income | 173 | ✕ | ✕ | ✕ | ✕ | |||
| Cost of revenue | (1,509) | (353) | ||||||
| Gross profit: | 173 | (59) | 255 | |||||
| Operating expenses | (31,528) | (36,289) | (23,486) | (14,301) | (12,171) | (13,552) | (12,415) | |
| Other operating expense, net (Other Nonrecurring (Income) Expense) | (590) | |||||||
| Other undisclosed operating income (loss) | (173) | 590 | ||||||
| Operating loss: | (31,528) | (36,289) | (23,486) | (14,301) | (12,171) | (13,610) | (12,160) | |
| Nonoperating income (expense) | 618 | 11,650 | (7,288) | 2,460 | (1,553) | 1,567 | ||
| Investment income, nonoperating | 1,994 | |||||||
| Other nonoperating income (expense) | 110 | 13 | 154 | (62) | (1,553) | 1,567 | ||
| Interest and debt expense | (2) | (1) | (3,049) | |||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 2 | 1 | 27,449 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (30,910) | (24,639) | (30,774) | (11,841) | 13,724 | (12,044) | (15,209) | |
| Loss from equity method investments | (478) | (160) | ||||||
| Other undisclosed income (loss) from continuing operations before income taxes | 160 | (27,449) | ||||||
| Loss from continuing operations before income taxes: | (30,910) | (24,639) | (31,252) | (11,841) | (13,724) | (12,044) | (15,209) | |
| Income tax expense (benefit) | 1,650 | (22) | ||||||
| Loss from continuing operations: | (30,910) | (24,639) | (31,252) | (11,841) | (12,074) | (12,065) | (15,209) | |
| Loss from discontinued operations | (1,494) | (3,594) | ||||||
| Loss before gain (loss) on sale of properties: | (30,910) | (24,639) | (31,252) | (13,335) | (15,667) | (12,065) | (15,209) | |
| Other undisclosed net income | 478 | |||||||
| Net loss: | (30,910) | (24,639) | (30,774) | (13,335) | (15,667) | (12,065) | (15,209) | |
| Other undisclosed net loss attributable to parent | (699) | |||||||
| Net loss attributable to parent: | (30,910) | (24,639) | (30,774) | (13,335) | (15,667) | (12,065) | (15,909) | |
| Preferred stock dividends and other adjustments | (3,651) | (3,049) | ||||||
| Net loss available to common stockholders, diluted: | (30,910) | (24,639) | (30,774) | (13,335) | (15,667) | (15,716) | (18,958) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (30,910) | (24,639) | (30,774) | (13,335) | (15,667) | (12,065) | (15,209) | |
| Comprehensive loss, net of tax, attributable to parent: | (30,910) | (24,639) | (30,774) | (13,335) | (15,667) | (12,065) | (15,209) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.